Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listhydrocortamate

hydrocortamate

  • CAS NO.:76-47-1
  • Empirical Formula: C27H41NO6
  • Molecular Weight: 475.62
  • MDL number: MFCD00864163
  • EINECS: 200-963-9
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2023-05-04 17:34:42
hydrocortamate Structural

What is hydrocortamate?

Toxicity

Side effects include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria.

Originator

Magnacort,Pfizer,US,1956

The Uses of hydrocortamate

Hydrocortamate is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.

Indications

Used topically as an antiinflammatory in the treatment of steroid-responsive dermatoses

Background

Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects.

Definition

ChEBI: Hydrocortamate is a glycinyl ester, an 11beta-hydroxy steroid, a 17alpha-hydroxy steroid, a glucocorticoid, a 3-oxo-Delta(4) steroid and a tertiary alpha-hydroxy ketone. It has a role as an anti-inflammatory drug and an immunosuppressive agent. It is functionally related to a cortisone.

Manufacturing Process

1 g of hydrocortisone is introduced with stirring into 5 cc of anhydrous pyridine. After heating to 45°C and then cooling again to 0°C to 5°C there is slowly added dropwise a freshly prepared solution of 0.52 g (1 mol + 10%) of chloracetic anhydride in 4 cc of absolute ether, The reaction temperature should not exceed 10°C. During the whole time of reaction a stream of nitrogen is passed through the reaction mixture in order to achieve an exhaustive evaporation of the added ether. The batch is slowly allowed to come to room temperature, an operation requiring 4 to 5 hours, and then 0.1 cc of water is added for decomposition of the excess of anhydride. The reaction solution is introduced dropwise with stirrinq within 1 hour into 100 cc of water as a result of which the 21-chloracetate of hydrocortisone is deposited. After filtration with suction, washing is carried out with water, 5% hydrochloric acid, water, 2% sodium bicarbonate solution and water again. The substance is then dried in a vacuum desiccator. The white chloracetate thus obtained melts at 213°C to 214°C with decomposition. It is free from nitrogen and the yield amounts to 93.4% of the theoretical.
1 g of hydrocortisone-21-chloracetate is dissolved in 15 cc of anhydrous and peroxide-free tetrahydrofuran. The solution produced is treated with a solution of 0.42 g of diethylamine in 15 cc of tetrahydrofuran. The reaction mixture is allowed to stand for 24 hours at room temperature. The separated diethylamine hydrochloride is filtered with suction and the filtrate evaporated under vacuum in a nitrogen atmosphere at 40°C. The residue is triturated with a little absolute ether and suction filtered. It is washed on the filter with a little ether and then with hexane. The 21-diethylaminoacetate of hydrocortisone melts at 150°C to 162°C. The base can be recrystallized from ethyl acetate but its melting point remains practically unchanged at 162°C to 163°C. The yield amounts to 72.5% of the theoretical. For conversion of the base into the hydrochloride it is suspended in ether and the suspension treated with ethereal hydrochloric acid. The hydrochloride is filtered with suction and recrystallized from ethanol; MP 222°C with decomposition.
With a starting quantity of 14g, the yield amounted to 85.4% of the theoretical.

brand name

Magnacort (Pfizer).

Therapeutic Function

Corticosteroid

Pharmacokinetics

Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated.

Metabolism

Primarily hepatic via CYP3A4

Properties of hydrocortamate

Melting point: 162-163°
Boiling point: 627.2±55.0 °C(Predicted)
Density  1.21±0.1 g/cm3(Predicted)
pka 12.32±0.70(Predicted)

Safety information for hydrocortamate

Computed Descriptors for hydrocortamate

Related products of tetrahydrofuran

You may like

  • 1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%
    1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%
    99903-60-3
    View Details
  • 88491-46-7 98%
    88491-46-7 98%
    88491-46-7
    View Details
  • 1823368-42-8 98%
    1823368-42-8 98%
    1823368-42-8
    View Details
  • 2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    1307449-08-6
    View Details
  • Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    25408-95-1
    View Details
  • 2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%
    2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%
    1805639-70-6
    View Details
  • 1784294-80-9 98%
    1784294-80-9 98%
    1784294-80-9
    View Details
  • Lithium Clavulanate
    Lithium Clavulanate
    61177-44-4
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.